Orbicular Pharmaceutical Technologies Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2008.
2008 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Orbicular Pharmaceutical Technologies Private Limited

Orbicular Pharmaceutical Technologies Private Limited, a active private limited company, was established on 13 August 2008 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24233TG2008PTC060606. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹11.18 Cr.

It upholds a compliant status. Employing 253 professional, Its leadership includes Mohan Sivaraman Mailtur (Managing Director), Bhavesh Vallabhbhai Patel (Director), Visalakshi Chandramouli (Nominee Director). Past directors included Mohan Sivaraman Mailtur, Melarkode Sankaraiyer Sivaraman, Bhavesh Vallabhbhai Patel. It holds ₹461.75 Cr open charges and ₹15.70 Cr settled loans. Its latest AGM occurred on 12 September 2025, with the balance sheet filed on 31 March 2025. It is based at P.No 53 , Aleap Industrial Estate, Gajularamaram Behind Pragathi Nagar, Kukatpally, Hyderabad, Telangana, 500090.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TG2008PTC060606

  • Registration Number

    060606

  • Incorporation Date

    13 August 2008

  • Authorized Capital

    ₹12.00 Cr

  • Paid-Up Capital

    ₹11.18 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 12.00 Cr
  • Paid Up Capital ₹ 11.18 Cr
  • Company Age 17 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 461.75 Cr
  • Satisfied Charges ₹ 15.70 Cr
  • Revenue Growth **** 6.18%
  • Profit Growth **** -54.08%
  • Ebitda **** 18.60%
  • Net Worth 12.15%
  • Total Assets **** 40.00%
Company report

Orbicular Pharmaceutical Technologies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Orbicular Pharmaceutical Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Orbicular Pharmaceutical Technologies Private Limited?
Current Directors
Name Designation Appointment Date Status
Mohan Sivaraman Mailtur Managing Director 06 Aug 2010 Current
Bhavesh Vallabhbhai Patel Director 01 Apr 2022 Current
Visalakshi Chandramouli Nominee Director 31 May 2024 Current
Meena Mohan Director 13 Aug 2008 Current
Hiren Dasharathbhai Patel Director 24 Aug 2012 Current
Rahul Gawande Sudhakar Director 01 Jul 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Aug 2010 Past
Pramod Abcsdd Director 19 Nov 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2022 Past
Pramod Abcsdd Additional Director 31 Mar 2022 Past
Pramod Abcsdd Additional Director 24 Aug 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orbicular Pharmaceutical Technologies.

Orbicular Pharmaceutical Technologies Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 6.18% increase. The company also saw a substantial fall in profitability, with a 54.08% decrease in profit. The company's net worth Soared by an impressive increase of 12.15%.

Orbicular Pharmaceutical Technologies revenue growth over time
Orbicular Pharmaceutical Technologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 6.18%
*******
*******
*******
*******
Revenue from Operations
*******
 5.85%
*******
*******
*******
*******
Total Assets
*******
 40.00%
*******
*******
*******
*******
Profit or Loss
*******
 -54.08%
*******
*******
*******
*******
Net Worth
*******
 12.15%
*******
*******
*******
*******
EBITDA
*******
 18.60%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orbicular Pharmaceutical Technologies?

In 2024, Orbicular Pharmaceutical Technologies had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,617,470,000.00

Satisfied Charges

₹157,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 301.75 Cr
  • Hdfc Bank Limited : 100.00 Cr
  • Standard Chartered Bank : 60.00 Cr
Latest Charge Details
Date Lender Amount Status
24 Nov 2025 Hdfc Bank Limited ₹40.00 Cr Open
24 Nov 2025 Hdfc Bank Limited ₹60.00 Cr Open
30 Oct 2025 Others ₹8.00 Cr Open
28 Jun 2025 Others ₹4.50 Cr Open
28 Jun 2025 Others ₹23.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Orbicular Pharmaceutical Technologies?

Orbicular Pharmaceutical Technologies has a workforce of 253 employees as of Dec 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Orbicular Pharmaceutical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orbicular Pharmaceutical Technologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orbicular Pharmaceutical Technologies
Recent Activity within the Organization
  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 40.00 Cr with Charge ID 101205765 was registered on 24 Nov 2025. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 60.00 Cr with Charge ID 101216682 was registered on 24 Nov 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 8.00 Cr with Charge ID 101203120 was registered on 30 Oct 2025. was completed.

  • Charges

    A charge with Others of Rs. 4.50 Cr registered on 28 Jun 2025 with Charge ID 101128736 was modified on 30 Oct 2025. was recorded as a recent event.

  • Annual General Meeting

    Orbicular Pharmaceutical Technologies Private Limited last Annual general meeting of members was held on 12 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 23.00 Cr with Charge ID 101128740 was registered on 28 Jun 2025. was completed.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Orbicular Pharmaceutical Technologies Private Limited?

The CIN of Orbicular Pharmaceutical Technologies Private Limited is U24233TG2008PTC060606.

Where is Orbicular Pharmaceutical Technologies Private Limited headquartered?

Orbicular Pharmaceutical Technologies Private Limited is headquartered at P.No 53 , Aleap Industrial Estate, Gajularamaram Behind Pragathi Nagar, Kukatpally, Hyderabad, Telangana, 500090.

When was Orbicular Pharmaceutical Technologies Private Limited incorporated?

Orbicular Pharmaceutical Technologies Private Limited was incorporated on 13 August 2008.

Who are the current directors of Orbicular Pharmaceutical Technologies Private Limited?

The current directors of Orbicular Pharmaceutical Technologies Private Limited are

What is the primary industry of Orbicular Pharmaceutical Technologies Private Limited?

The primary industry of Orbicular Pharmaceutical Technologies Private Limited is Professional, Scientific And Technical.

Is Orbicular Pharmaceutical Technologies Private Limited a listed company?

Orbicular Pharmaceutical Technologies Private Limited is unlisted.

What is the capital structure of Orbicular Pharmaceutical Technologies Private Limited?

The authorized capital of Orbicular Pharmaceutical Technologies Private Limited is ₹12.00 Cr, and the paid-up capital is ₹11.18 Cr.

What is the compliance status of Orbicular Pharmaceutical Technologies Private Limited?

The compliance status of Orbicular Pharmaceutical Technologies Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available